Individualized antibiotic dosage regimens for patients with augmented renal clearance

被引:14
|
作者
Shi, A-Xi [1 ,2 ]
Qu, Qiang [3 ,4 ,5 ]
Zhuang, Hai-Hui [1 ]
Teng, Xin-Qi [1 ]
Xu, Wei-Xin [1 ]
Liu, Yi-Ping [1 ]
Xiao, Yi-Wen [1 ]
Qu, Jian [1 ,5 ]
机构
[1] Cent South Univ, Xiangya Hosp 2, Inst Clin Pharm, Dept Pharm, Changsha, Peoples R China
[2] First Hosp Lanzhou Univ, Dept Pharm, Lanzhou, Peoples R China
[3] Cent South Univ, Xiangya Hosp, Dept Pharm, Changsha, Peoples R China
[4] Cent South Univ, Xiangya Hosp, Natl Clin Res Ctr Geriatr Disorders, Changsha, Peoples R China
[5] Changsha Med Univ, Hunan Key Lab Res & Dev Novel Pharmaceut Preparat, Changsha, Peoples R China
关键词
augmented renal clearance; antibiotic; pharmacokinetics; pharmacodynamics; individualized; CRITICALLY-ILL PATIENTS; INFECTIOUS-DISEASES SOCIETY; STAPHYLOCOCCUS-AUREUS INFECTIONS; VITRO ANTIMICROBIAL ACTIVITY; AMOXICILLIN-CLAVULANIC ACID; MONTE-CARLO-SIMULATION; POPULATION PHARMACOKINETICS; ANTIBACTERIAL ACTIVITY; PSEUDOMONAS-AERUGINOSA; CREATININE CLEARANCE;
D O I
10.3389/fphar.2023.1137975
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objectives: Augmented renal clearance (ARC) is a state of enhanced renal function commonly observed in 30%-65% of critically ill patients despite normal serum creatinine levels. Using unadjusted standard dosing regimens of renally eliminated drugs in ARC patients often leads to subtherapeutic concentrations, poor clinical outcomes, and the emergence of multidrug-resistant bacteria. We summarized pharmaceutical, pharmacokinetic, and pharmacodynamic research on the definition, underlying mechanisms, and risk factors of ARC to guide individualized dosing of antibiotics and various strategies for optimizing outcomes.Methods: We searched for articles between 2010 and 2022 in the MEDLINE database about ARC patients and antibiotics and further provided individualized antibiotic dosage regimens for patients with ARC.Results: 25 antibiotic dosage regimens for patients with ARC and various strategies for optimization of outcomes, such as extended infusion time, continuous infusion, increased dosage, and combination regimens, were summarized according to previous research.Conclusion: ARC patients, especially critically ill patients, need to make individualized adjustments to antibiotics, including dose, frequency, and method of administration. Further comprehensive research is required to determine ARC staging, expand the range of recommended antibiotics, and establish individualized dosing guidelines for ARC patients.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] ARC - Augmented Renal Clearance
    Udy, Andrew A.
    Putt, Michael T.
    Boots, Robert J.
    Lipman, Jeffrey
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2011, 12 (12) : 2020 - 2029
  • [32] APPLICATION OF INDIVIDUALIZED DIGOXIN DOSAGE REGIMENS TO CANINE THERAPEUTIC DIGITALIZATION
    BUTTON, C
    GROSS, DR
    ALLERT, JA
    AMERICAN JOURNAL OF VETERINARY RESEARCH, 1980, 41 (08) : 1238 - 1242
  • [33] Augmented Renal Clearance in Critically Ill Patients: A Systematic Review
    Bilbao-Meseguer, Idoia
    Rodriguez-Gascon, Alicia
    Barrasa, Helena
    Isla, Arantxazu
    Angeles Solinis, Maria
    CLINICAL PHARMACOKINETICS, 2018, 57 (09) : 1107 - 1121
  • [34] PREDICTORS OF AUGMENTED RENAL CLEARANCE IN CRITICALLY ILL PATIENTS WITH CANCER
    Nazer, Lama
    Sheikha, Lama
    Anabtawi, Nadeen
    Le, Jennifer
    CRITICAL CARE MEDICINE, 2019, 47
  • [35] Augmented Renal Clearance in Critically Ill Patients: A Systematic Review
    Idoia Bilbao-Meseguer
    Alicia Rodríguez-Gascón
    Helena Barrasa
    Arantxazu Isla
    María Ángeles Solinís
    Clinical Pharmacokinetics, 2018, 57 : 1107 - 1121
  • [36] Population pharmacokinetics of vancomycin in Chinese patients with augmented renal clearance
    Chu, Yang
    Luo, Yifan
    Ji, Shuangmin
    Jiang, Mingyan
    Zhou, Baosen
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2020, 13 (01) : 68 - 74
  • [37] Augmented renal clearance in septic patients and implications for vancomycin optimisation
    Baptista, Joao Pedro
    Sousa, Eduardo
    Martins, Paulo J.
    Pimentel, Jorge M.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2012, 39 (05) : 420 - 423
  • [38] Optimizing Aminoglycoside Dosing Regimens for Critically III Pediatric Patients with Augmented Renal Clearance: a Convergence of Parametric and Nonparametric Population Approaches
    Avedissian, Sean N.
    Rohani, Roxane
    Bradley, John
    Le, Jennifer
    Rhodes, Nathaniel J.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (04)
  • [39] Increased dosing regimens of piperacillin-tazobactam are needed to avoid subtherapeutic exposure in critically ill patients with augmented renal clearance
    Besnard, Thibaud
    Carrie, Cedric
    Petit, Laurent
    Biais, Matthieu
    CRITICAL CARE, 2019, 23 (1):
  • [40] Increased dosing regimens of piperacillin-tazobactam are needed to avoid subtherapeutic exposure in critically ill patients with augmented renal clearance
    Thibaud Besnard
    Cédric Carrié
    Laurent Petit
    Matthieu Biais
    Critical Care, 23